Analysen von Michael Leuchten
| 08.06.20 | AstraZeneca Sell | UBS AG | |
| 08.06.20 | Sartorius vz. Sell | UBS AG | |
| 04.06.20 | AstraZeneca Sell | UBS AG | |
| 27.05.20 | AstraZeneca Sell | UBS AG | |
| 25.05.20 | AstraZeneca Sell | UBS AG | |
| 22.05.20 | AstraZeneca Sell | UBS AG | |
| 29.04.20 | AstraZeneca Sell | UBS AG | |
| 09.03.20 | AstraZeneca Sell | UBS AG | |
|
Werbung
|
|||
| 18.02.20 | AstraZeneca Sell | UBS AG | |
| 03.02.20 | AstraZeneca Sell | UBS AG | |
| 12.12.19 | AstraZeneca Sell | UBS AG | |
| 09.12.19 | AstraZeneca Sell | UBS AG | |
| 03.12.19 | AstraZeneca Sell | UBS AG | |
| 11.11.19 | AstraZeneca Sell | UBS AG | |
| 29.10.19 | AstraZeneca Sell | UBS AG | |
| 24.10.19 | AstraZeneca Sell | UBS AG | |
| 10.09.19 | AstraZeneca Sell | UBS AG | |
| 25.07.19 | AstraZeneca Sell | UBS AG | |
| 03.06.19 | AstraZeneca Sell | UBS AG | |
| 13.05.19 | AstraZeneca Sell | UBS AG | |
| 07.05.19 | AstraZeneca Sell | UBS AG | |
| 26.04.19 | AstraZeneca Sell | UBS AG | |
| 14.04.16 | Novartis Underweight | Barclays Capital | |
| 19.02.16 | Bayer Underweight | Barclays Capital | |
| 28.01.16 | Novartis Underweight | Barclays Capital | |
| 15.01.16 | Novartis Underweight | Barclays Capital | |
| 05.01.16 | Bayer Underweight | Barclays Capital | |
| 10.07.15 | Bayer Underweight | Barclays Capital | |
| 27.02.15 | Bayer Underweight | Barclays Capital | |
| 13.02.15 | Bayer Underweight | Barclays Capital | |
| 12.08.14 | Merck Underweight | Barclays Capital | |
| 16.05.14 | Merck Underweight | Barclays Capital | |
| 14.05.14 | Merck Underweight | Barclays Capital | |